Windtree Therapeutics Inc. (WINT) NASDAQ
$5.10 (0.06) (-1.07%)
Market Cap: $47.34M
As of 04/25/24 12:24 PM EDT. Market open.
Windtree Therapeutics Inc. (WINT)
NASDAQ
$5.10
(0.06) (-1.07%)
Market Cap: $47.34M
As of 04/25/24 12:24 PM EDT. Market open.
Add to Portfolio
windtree therapeutics, inc. is a biotechnology company focused on developing novel kl4 surfactant therapies for respiratory diseases and other potential applications. windtree’s proprietary technology platform includes a synthetic, peptide-containing surfactant (kl4 surfactant ) that is structurally similar to human pulmonary surfactant — and novel drug-delivery technologies that are being ... read more
COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
Full Time Employees
21
URL
Address
.
PRICE CHART FOR WINDTREE THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$5.14
Previous Close
$5.16
Days Range
$4.89 - $5.18
52 week range
$4.78 - $35.10
Volume
5,808
Avg. Volume (30 days)
21,502
Market Cap
$47.34M
Dividend Yield
-
P/E
-
Shares Outstanding
9,183,220
Open
$5.14
Previous Close
$5.16
Days Range
$4.89 - $5.18
52 week range
$4.78 - $35.10
Volume
5,808
Avg. Volume (30 days)
21,502
Market Cap
$47.34M
Dividend Yield
-
P/E
-
Shares Outstanding
9,183,220
FINANCIAL STATEMENTS FOR WINDTREE THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR WINDTREE THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Fraser Craig | President and CEO | Sep 27, 2023 | Buy | $1.02 | 2,500 | 2,550 | 57,877 | Sep 28, 2023, 07:24 AM |
| Fraser Craig | President and CEO | Sep 26, 2023 | Buy | $0.90 | 2,500 | 2,250 | 55,377 | Sep 27, 2023, 07:34 AM |
| Fraser Craig | President and CEO | Apr 26, 2023 | Buy | $1.77 | 1,497 | 2,650 | 7,010 | Apr 27, 2023, 07:41 AM |
| Fraser Craig | President and CEO | Apr 25, 2023 | Buy | $1.89 | 1,315 | 2,485 | 5,513 | Apr 26, 2023, 07:21 AM |
| Huang James | Director | Feb 22, 2023 | Option Exercise | $0.14 | 1,112,308 | 156,947 | 3,449,161 | Feb 23, 2023, 04:30 PM |
| Fraser Craig | President and CEO | Jul 27, 2022 | Buy | $0.38 | 2,500 | 950 | 226,558 | Jul 27, 2022, 04:20 PM |
| Hamill John P. | SVP & CFO | Jul 26, 2022 | Buy | $0.37 | 3,000 | 1,100 | 72,800 | Jul 26, 2022, 04:38 PM |
| Fraser Craig | President and CEO | Jul 26, 2022 | Buy | $0.37 | 2,500 | 935 | 224,058 | Jul 26, 2022, 04:37 PM |
| Fraser Craig | President and CEO | Jun 30, 2022 | Buy | $0.43 | 4,500 | 1,926 | 221,558 | Jul 05, 2022, 04:40 PM |
| Fraser Craig | President and CEO | Jun 29, 2022 | Buy | $0.42 | 7,000 | 2,908 | 217,058 | Jun 30, 2022, 06:59 AM |
| Fraser Craig | President and CEO | Mar 16, 2022 | Buy | $0.98 | 2,000 | 1,960 | 210,058 | Mar 17, 2022, 05:33 PM |
| Simonson Steven | SVP, Chief Medical Officer | Mar 15, 2022 | Buy | $1.00 | 5,000 | 4,999 | 83,602 | Mar 15, 2022, 04:48 PM |
| Fraser Craig | President and CEO | Mar 15, 2022 | Buy | $0.98 | 3,000 | 2,940 | 208,058 | Mar 15, 2022, 04:45 PM |
| Center Laboratories, Inc. | 10% Owner | Dec 30, 2021 | Buy | $1.60 | 1,239,088 | 1,982,541 | 1,239,088 | Jan 10, 2022, 05:03 PM |
| Center Laboratories, Inc. | 10% Owner | May 20, 2020 | Buy | $7.25 | 55,172 | 399,997 | 1,239,088 | Jan 10, 2022, 05:03 PM |
| Bioengine Capital Inc. | 10% Owner | May 20, 2020 | Buy | $7.25 | 55,172 | 399,997 | 1,239,088 | Jan 10, 2022, 05:03 PM |
| Bioengine Capital Inc. | 10% Owner | Dec 30, 2021 | Sale | $1.60 | 1,239,088 | 1,982,541 | 0 | Jan 10, 2022, 05:03 PM |
| Fraser Craig | President and CEO | Nov 19, 2021 | Buy | $1.60 | 930 | 1,488 | 38,158 | Nov 22, 2021, 08:35 AM |
| Fraser Craig | President and CEO | Nov 18, 2021 | Buy | $1.61 | 930 | 1,497 | 37,228 | Nov 18, 2021, 04:25 PM |
| Fraser Craig | President and CEO | Oct 22, 2021 | Buy | $1.90 | 3,000 | 5,700 | 36,298 | Oct 25, 2021, 09:17 AM |
| Huang James | Director | Oct 19, 2021 | Buy | $1.90 | 50,000 | 95,135 | 291,281 | Oct 19, 2021, 04:56 PM |
| Fraser Craig | President and CEO | Oct 19, 2021 | Buy | $1.91 | 3,000 | 5,730 | 33,298 | Oct 19, 2021, 04:51 PM |
| Hamill John P. | SVP & CFO | Apr 16, 2021 | Buy | $2.07 | 1,000 | 2,067 | 3,500 | Apr 19, 2021, 07:49 AM |
| Curtis Eric | SVP & COO | Apr 07, 2021 | Buy | $2.52 | 791 | 1,991 | 1,291 | Apr 08, 2021, 04:16 PM |
| Fraser Craig | President and CEO | Apr 06, 2021 | Buy | $2.57 | 500 | 1,285 | 28,298 | Apr 07, 2021, 04:18 PM |
| Fraser Craig | President and CEO | Apr 01, 2021 | Buy | $2.46 | 500 | 1,229 | 26,798 | Apr 05, 2021, 08:06 AM |
| Huang James | Director | Mar 31, 2021 | Buy | $2.36 | 150,000 | 354,000 | 171,000 | Apr 02, 2021, 05:13 PM |
| Fraser Craig | President and CEO | Mar 31, 2021 | Buy | $2.32 | 500 | 1,160 | 26,298 | Mar 31, 2021, 04:30 PM |
| Simonson Steven | SVP, Chief Medical Officer | Mar 25, 2021 | Buy | $3.25 | 1,500 | 4,875 | 12,302 | Mar 25, 2021, 04:45 PM |
| Hamill John P. | SVP & CFO | Mar 25, 2021 | Buy | $3.25 | 1,500 | 4,875 | 2,500 | Mar 25, 2021, 04:44 PM |
| Fraser Craig | President and CEO | Mar 25, 2021 | Buy | $3.25 | 1,500 | 4,875 | 25,798 | Mar 25, 2021, 04:43 PM |
| Fraser Craig | President and CEO | Oct 28, 2020 | Buy | $6.56 | 250 | 1,640 | 24,298 | Oct 29, 2020, 06:08 AM |
| Huang James | Director | Oct 23, 2020 | Buy | $6.67 | 1,000 | 6,666 | 21,000 | Oct 27, 2020, 06:02 AM |
| Huang James | Director | Jun 04, 2020 | Buy | $7.32 | 12,000 | 87,868 | 20,000 | Oct 26, 2020, 06:26 PM |
| Fraser Craig | President and CEO | Oct 09, 2020 | Buy | $5.82 | 250 | 1,456 | 24,048 | Oct 13, 2020, 08:40 AM |
| Hamill John P. | SVP & CFO | Oct 07, 2020 | Buy | $5.27 | 1,000 | 5,270 | 1,000 | Oct 09, 2020, 08:06 AM |
| Fraser Craig | President and CEO | Oct 07, 2020 | Buy | $5.17 | 250 | 1,293 | 23,798 | Oct 09, 2020, 08:05 AM |
| Curtis Eric | SVP & COO | Oct 08, 2020 | Buy | $5.27 | 500 | 2,635 | 500 | Oct 09, 2020, 08:03 AM |
| Huang James | Director | Jun 04, 2020 | Buy | $7.32 | 12,200 | 89,332 | 20,200 | Jun 05, 2020, 08:36 PM |
| Huang James | Director | Jun 03, 2020 | Buy | $7.42 | 200 | 1,484 | 8,000 | Jun 05, 2020, 08:36 PM |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | May 22, 2020 | Buy | $7.25 | 1,103 | 7,997 | 1,134 | May 27, 2020, 09:56 PM |
| Tattory John A | SVP & CFO | May 22, 2020 | Buy | $7.25 | 449 | 3,255 | 9,280 | May 27, 2020, 09:55 PM |
| Simonson Steven | SVP, Chief Medical Officer | May 22, 2020 | Buy | $7.25 | 517 | 3,748 | 10,802 | May 27, 2020, 09:54 PM |
| Fraser Craig | President and CEO | May 22, 2020 | Buy | $7.25 | 2,069 | 15,000 | 23,548 | May 27, 2020, 09:44 PM |
| Schreiber Brian D | Director | May 22, 2020 | Buy | $7.25 | 2,069 | 15,000 | 2,069 | May 27, 2020, 09:43 PM |
| PEACOCK BRUCE | Director | May 22, 2020 | Buy | $7.25 | 3,500 | 25,375 | 8,886 | May 27, 2020, 09:41 PM |
| Joseph Mahady M | Director | May 22, 2020 | Buy | $7.25 | 2,069 | 15,000 | 7,455 | May 27, 2020, 09:40 PM |
| Leone John R | Director | May 22, 2020 | Buy | $7.25 | 2,069 | 15,000 | 7,473 | May 27, 2020, 09:39 PM |
| Huang James | Director | May 22, 2020 | Buy | $7.25 | 275,862 | 2,000,000 | 2,336,853 | May 27, 2020, 09:37 PM |
| Geffken Daniel E. | Director | May 22, 2020 | Buy | $7.25 | 2,069 | 15,000 | 2,069 | May 27, 2020, 09:36 PM |
| Huang James | Director | Feb 18, 2020 | Buy | $3.84 | 400 | 1,535 | 23,400 | Feb 20, 2020, 04:21 PM |
| Fraser Craig | President and CEO | Feb 11, 2020 | Buy | $4.10 | 250 | 1,025 | 63,590 | Feb 12, 2020, 04:07 PM |
| Fraser Craig | President and CEO | Feb 10, 2020 | Buy | $4.10 | 250 | 1,025 | 63,340 | Feb 12, 2020, 04:07 PM |
| Huang James | Director | Feb 07, 2020 | Buy | $4.05 | 500 | 2,025 | 23,000 | Feb 07, 2020, 05:11 PM |
| Fraser Craig | President and CEO | Feb 04, 2020 | Buy | $4.24 | 500 | 2,120 | 63,090 | Feb 05, 2020, 04:14 PM |
| Fraser Craig | President and CEO | Feb 03, 2020 | Buy | $4.20 | 100 | 420 | 62,590 | Feb 05, 2020, 04:14 PM |
| Huang James | Director | Jan 16, 2020 | Buy | $4.20 | 58 | 244 | 20,500 | Jan 21, 2020, 08:52 PM |
| Huang James | Director | Jan 17, 2020 | Buy | $4.18 | 2,000 | 8,366 | 22,500 | Jan 21, 2020, 08:52 PM |
| Huang James | Director | Dec 31, 2019 | Buy | $4.05 | 15,442 | 62,525 | 20,442 | Jan 03, 2020, 04:41 PM |
| Huang James | Director | Dec 30, 2019 | Buy | $3.81 | 909 | 3,463 | 5,000 | Dec 31, 2019, 04:08 PM |
| Huang James | Director | Dec 27, 2019 | Buy | $3.73 | 4,091 | 15,261 | 4,091 | Dec 31, 2019, 04:08 PM |
| LPH II Investments Ltd | 10% Owner | Dec 06, 2019 | Buy | $3.02 | 1,655,629 | 5,000,000 | 4,008,234 | Dec 10, 2019, 07:55 PM |
| Lee's Pharmaceutical Holdings Ltd | 10% Owner | Dec 06, 2019 | Buy | $3.02 | 1,655,629 | 5,000,000 | 14,450,599 | Dec 10, 2019, 07:54 PM |
| Huang James | Director | Dec 06, 2019 | Buy | $3.02 | 1,655,629 | 5,000,000 | 6,182,974 | Dec 10, 2019, 04:36 PM |
| Tattory John A | SVP & CFO | Dec 28, 2018 | Option Exercise | $5.00 | 8,007 | 40,035 | 36,203 | Jan 02, 2019, 05:20 PM |
| Simonson Steven | SVP, Chief Medical Officer | Dec 28, 2018 | Option Exercise | $5.00 | 7,402 | 37,010 | 39,835 | Jan 02, 2019, 05:13 PM |
| Fraser Craig | President and CEO | Dec 28, 2018 | Option Exercise | $5.00 | 15,553 | 77,765 | 83,982 | Jan 02, 2019, 05:10 PM |
| Lee's Pharmaceutical Holdings Ltd | 10% Owner | Dec 21, 2018 | Buy | $4.00 | 9,874,799 | 39,459,229 | 12,794,970 | Dec 26, 2018, 04:30 PM |
| LPH II Investments Ltd | 10% Owner | Dec 21, 2018 | Buy | $3.31 | 1,810,938 | 5,994,205 | 2,352,605 | Dec 26, 2018, 04:28 PM |
| Lee's Pharmaceutical Holdings Ltd | 10% Owner | Apr 04, 2018 | Buy | $4.80 | 541,667 | 2,600,002 | 2,853,271 | Apr 06, 2018, 01:54 PM |
| Fraser Craig | President and CEO | Oct 28, 2016 | Buy | $2.05 | 7,500 | 15,381 | 7,500 | Nov 01, 2016, 08:27 AM |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | Jun 30, 2016 | Option Exercise | $1.93 | 1,166 | 2,250 | 9,270 | Aug 01, 2016, 07:05 PM |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | Mar 31, 2016 | Option Exercise | $1.67 | 1,347 | 2,249 | 8,104 | Aug 01, 2016, 07:05 PM |
| Tattory John A | SVP & CFO | Jun 30, 2016 | Option Exercise | $1.93 | 1,088 | 2,100 | 6,555 | Aug 01, 2016, 07:04 PM |
| Tattory John A | SVP & CFO | Mar 31, 2016 | Option Exercise | $1.67 | 1,077 | 1,799 | 5,467 | Aug 01, 2016, 07:04 PM |
| Simonson Steven | SVP, Chief Development Officer | Jun 30, 2016 | Option Exercise | $1.93 | 1,166 | 2,250 | 6,884 | Aug 01, 2016, 07:04 PM |
| Simonson Steven | SVP, Chief Development Officer | Mar 31, 2016 | Option Exercise | $1.67 | 1,347 | 2,249 | 5,718 | Aug 01, 2016, 07:04 PM |
| Fraser Craig | President and CEO | Jun 30, 2016 | Option Exercise | $1.93 | 1,078 | 2,081 | 1,078 | Aug 01, 2016, 07:01 PM |
| Tattory John A | Senior VP and CFO | Dec 31, 2015 | Option Exercise | $2.99 | 827 | 2,473 | 4,390 | Feb 03, 2016, 06:47 PM |
| Tattory John A | Senior VP and CFO | Sep 30, 2015 | Option Exercise | $4.20 | 607 | 2,549 | 3,563 | Feb 03, 2016, 06:47 PM |
| Simonson Steven | SVP, Chief Development Officer | Dec 31, 2015 | Option Exercise | $2.99 | 2,630 | 7,864 | 4,372 | Feb 03, 2016, 06:47 PM |
| Simonson Steven | SVP, Chief Development Officer | Sep 30, 2015 | Option Exercise | $4.20 | 804 | 3,377 | 1,742 | Feb 03, 2016, 06:47 PM |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | Dec 31, 2015 | Option Exercise | $2.99 | 2,630 | 7,864 | 6,758 | Feb 03, 2016, 06:46 PM |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | Sep 30, 2015 | Option Exercise | $4.20 | 804 | 3,377 | 4,128 | Feb 03, 2016, 06:46 PM |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | Jun 30, 2015 | Option Exercise | $0.68 | 4,964 | 3,376 | 46,530 | Jul 24, 2015, 04:39 PM |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | Mar 31, 2015 | Option Exercise | $1.19 | 2,836 | 3,375 | 41,566 | Jul 24, 2015, 04:39 PM |
| Tattory John A | SVP & Chief Financial Officer | Mar 31, 2015 | Option Exercise | $1.19 | 2,458 | 2,925 | 37,087 | Jul 24, 2015, 04:38 PM |
| Tattory John A | SVP & Chief Financial Officer | Jun 30, 2015 | Option Exercise | $0.68 | 4,301 | 2,925 | 41,388 | Jul 24, 2015, 04:38 PM |
| Simonson Steven | SVP, Chief Development Officer | Jun 30, 2015 | Option Exercise | $0.68 | 4,964 | 3,376 | 13,132 | Jul 24, 2015, 04:37 PM |
| Simonson Steven | SVP, Chief Development Officer | Mar 31, 2015 | Option Exercise | $1.19 | 2,836 | 3,375 | 8,168 | Jul 24, 2015, 04:37 PM |
| COOPER JOHN G | President & CEO | Jun 30, 2015 | Option Exercise | $0.68 | 4,964 | 3,376 | 47,511 | Jul 24, 2015, 04:36 PM |
| COOPER JOHN G | President & CEO | Mar 31, 2015 | Option Exercise | $1.19 | 2,836 | 3,375 | 42,547 | Jul 24, 2015, 04:36 PM |
| Leone John R | Director | Feb 19, 2013 | Buy | $2.88 | 3,000 | 8,640 | 3,000 | Feb 20, 2013, 04:03 PM |
| Hoy Thomas | VP, Manufacturing | Mar 31, 2012 | Option Exercise | $2.68 | 1,585 | 4,248 | 10,781 | May 08, 2012, 04:23 PM |
| Tattory John A | VP, Finance (Prin Acc Officer) | Mar 31, 2012 | Option Exercise | $2.68 | 1,455 | 3,899 | 11,819 | May 08, 2012, 04:18 PM |
| Cole Kathy | Senior VP, Human Resources | Mar 31, 2012 | Option Exercise | $2.68 | 1,586 | 4,250 | 13,989 | May 08, 2012, 04:16 PM |
| Templeton Mary B Esq | Senior VP, General Counsel | Mar 31, 2012 | Option Exercise | $2.68 | 1,539 | 4,125 | 13,925 | May 08, 2012, 04:15 PM |
| Clayton Russell | Senior VP, R&D | Mar 31, 2012 | Option Exercise | $2.68 | 1,586 | 4,250 | 4,232 | May 08, 2012, 04:14 PM |
| Miller Thomas F | Chief Operating Officer | Mar 31, 2012 | Option Exercise | $2.68 | 1,586 | 4,250 | 14,110 | May 08, 2012, 04:12 PM |
| COOPER JOHN G | President & CFO | Mar 31, 2012 | Option Exercise | $2.68 | 1,586 | 4,250 | 14,281 | May 08, 2012, 04:11 PM |
| Amick W Thomas | Chief Executive Officer | Mar 31, 2012 | Option Exercise | $2.68 | 1,586 | 4,250 | 10,614 | May 08, 2012, 04:09 PM |
| Hoy Thomas | VP, Manufacturing | Sep 30, 2011 | Option Exercise | $1.96 | 2,104 | 4,124 | 6,740 | Oct 11, 2011, 04:33 PM |
| Hoy Thomas | VP, Manufacturing | Jun 30, 2011 | Option Exercise | $2.09 | 1,974 | 4,126 | 6,740 | Oct 11, 2011, 04:33 PM |
| Hoy Thomas | VP, Manufacturing | Mar 31, 2011 | Option Exercise | $1.85 | 2,230 | 4,126 | 6,740 | Oct 11, 2011, 04:33 PM |
| Tattory John A | VP, Principal Acct Officer | Sep 30, 2011 | Option Exercise | $1.96 | 1,837 | 3,601 | 8,221 | Oct 11, 2011, 04:32 PM |
| Tattory John A | VP, Principal Acct Officer | Jun 30, 2011 | Option Exercise | $2.09 | 1,722 | 3,599 | 8,221 | Oct 11, 2011, 04:32 PM |
| Tattory John A | VP, Principal Acct Officer | Mar 31, 2011 | Option Exercise | $1.85 | 1,946 | 3,600 | 8,221 | Oct 11, 2011, 04:32 PM |
| Templeton Mary B Esq | Senior VP, General Counsel | Sep 30, 2011 | Option Exercise | $1.96 | 2,105 | 4,126 | 9,931 | Oct 11, 2011, 04:31 PM |
| Cole Kathy | Senior VP, Human Resources | Mar 31, 2011 | Option Exercise | $1.85 | 2,230 | 4,126 | 9,948 | Oct 11, 2011, 04:30 PM |
| Cole Kathy | Senior VP, Human Resources | Sep 30, 2011 | Option Exercise | $1.96 | 2,105 | 4,126 | 9,948 | Oct 11, 2011, 04:30 PM |
| Cole Kathy | Senior VP, Human Resources | Jun 30, 2011 | Option Exercise | $2.09 | 1,974 | 4,126 | 9,948 | Oct 11, 2011, 04:30 PM |
| Miller Thomas F | Chief Operating Officer | Sep 30, 2011 | Option Exercise | $1.96 | 2,105 | 4,126 | 10,069 | Oct 11, 2011, 04:29 PM |
| Miller Thomas F | Chief Operating Officer | Jun 30, 2011 | Option Exercise | $2.09 | 1,974 | 4,126 | 10,069 | Oct 11, 2011, 04:29 PM |
| Miller Thomas F | Chief Operating Officer | Mar 31, 2011 | Option Exercise | $1.85 | 2,230 | 4,126 | 10,069 | Oct 11, 2011, 04:29 PM |
| COOPER JOHN G | President & CFO | Sep 30, 2011 | Option Exercise | $1.96 | 2,104 | 4,124 | 10,239 | Oct 11, 2011, 04:28 PM |
| Amick W Thomas | Chief Executive Officer | Sep 30, 2011 | Option Exercise | $1.96 | 2,105 | 4,126 | 6,573 | Oct 11, 2011, 04:27 PM |
| Amick W Thomas | Chief Executive Officer | Jun 30, 2011 | Option Exercise | $2.09 | 1,973 | 4,124 | 4,468 | Aug 17, 2011, 05:48 PM |
| Amick W Thomas | Chief Executive Officer | Mar 31, 2011 | Option Exercise | $1.85 | 2,230 | 4,126 | 2,495 | Aug 17, 2011, 05:48 PM |
| COOPER JOHN G | President & CFO | Mar 31, 2011 | Option Exercise | $1.85 | 2,230 | 4,126 | 6,161 | Aug 17, 2011, 05:48 PM |
| COOPER JOHN G | President & CFO | Jun 30, 2011 | Option Exercise | $2.09 | 1,974 | 4,126 | 8,135 | Aug 17, 2011, 05:48 PM |
| LOPEZ DAVID L | Executive VP & General Counsel | Jun 30, 2011 | Option Exercise | $2.09 | 1,974 | 4,126 | 8,033 | Aug 01, 2011, 08:33 AM |
| LOPEZ DAVID L | Executive VP & General Counsel | Mar 31, 2011 | Option Exercise | $1.85 | 2,230 | 4,126 | 6,059 | Aug 01, 2011, 08:33 AM |
| LOPEZ DAVID L | Executive VP & Legal Counsel | Sep 30, 2010 | Option Exercise | $0.21 | 9,337 | 1,961 | 47,722 | Dec 21, 2010, 03:22 PM |
| LOPEZ DAVID L | Executive VP & Legal Counsel | Dec 17, 2010 | Sale | $0.21 | 17,000 | 3,598 | 278,134 | Dec 21, 2010, 03:22 PM |
| Cole Kathy | Senior VP, Human Resources | Jun 30, 2010 | Option Exercise | $0.19 | 10,857 | 2,063 | 35,049 | Sep 29, 2010, 09:01 AM |
| Cole Kathy | Senior VP, Human Resources | Mar 31, 2010 | Option Exercise | $0.52 | 3,966 | 2,062 | 24,192 | Sep 29, 2010, 09:01 AM |
| COOPER JOHN G | Executive VP & CFO | Jun 30, 2010 | Option Exercise | $0.19 | 10,857 | 2,063 | 39,417 | Jul 30, 2010, 12:11 PM |
| COOPER JOHN G | Executive VP & CFO | Mar 31, 2010 | Option Exercise | $0.52 | 3,966 | 2,062 | 28,560 | Jul 30, 2010, 12:11 PM |
| COOPER JOHN G | Executive VP & CFO | Jan 03, 2010 | Option Exercise | $0.63 | 3,312 | 2,087 | 39,688 | Jul 30, 2010, 12:11 PM |
| SEGAL ROBERT-MD | SVO, Chief Medical Officer | Jun 30, 2010 | Option Exercise | $0.19 | 10,855 | 2,062 | 39,415 | Jul 29, 2010, 05:03 PM |
| SEGAL ROBERT-MD | SVO, Chief Medical Officer | Mar 31, 2010 | Option Exercise | $0.52 | 3,967 | 2,063 | 28,560 | Jul 29, 2010, 05:03 PM |
| SEGAL ROBERT-MD | SVO, Chief Medical Officer | Jan 03, 2010 | Option Exercise | $0.63 | 1,472 | 927 | 4,528 | Jul 29, 2010, 05:03 PM |
| Miller Thomas F | SVP, Commercial & Corp Dev | Jun 30, 2010 | Option Exercise | $0.19 | 10,857 | 2,063 | 36,852 | Jul 29, 2010, 04:56 PM |
| Miller Thomas F | SVP, Commercial & Corp Dev | Mar 31, 2010 | Option Exercise | $0.52 | 3,966 | 2,062 | 25,995 | Jul 29, 2010, 04:56 PM |
| Miller Thomas F | SVP, Commercial & Corp Dev | Jan 03, 2010 | Option Exercise | $0.63 | 1,105 | 696 | 6,895 | Jul 29, 2010, 04:56 PM |
| LOPEZ DAVID L | Executive VP & Legal Counsel | Jun 30, 2010 | Option Exercise | $0.19 | 11,390 | 2,164 | 38,385 | Jul 29, 2010, 04:17 PM |
| LOPEZ DAVID L | Executive VP & Legal Counsel | Mar 31, 2010 | Option Exercise | $0.52 | 3,606 | 1,875 | 26,995 | Jul 29, 2010, 04:17 PM |
| LOPEZ DAVID L | Executive VP & Legal Counsel | Jan 03, 2010 | Option Exercise | $0.63 | 3,312 | 2,087 | 53,834 | Jul 29, 2010, 04:17 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Fraser Craig | President and CEO | 09/27/2023 | 2,550 |
| Fraser Craig | President and CEO | 09/26/2023 | 2,250 |
| Fraser Craig | President and CEO | 04/26/2023 | 2,650 |
| Fraser Craig | President and CEO | 04/25/2023 | 2,485 |
| Huang James | Director | 02/22/2023 | 156,947 |
| Fraser Craig | President and CEO | 07/27/2022 | 950 |
| Hamill John P. | SVP & CFO | 07/26/2022 | 1,100 |
| Fraser Craig | President and CEO | 07/26/2022 | 935 |
| Fraser Craig | President and CEO | 06/30/2022 | 1,926 |
| Fraser Craig | President and CEO | 06/29/2022 | 2,908 |
| Fraser Craig | President and CEO | 03/16/2022 | 1,960 |
| Simonson Steven | SVP, Chief Medical Officer | 03/15/2022 | 4,999 |
| Fraser Craig | President and CEO | 03/15/2022 | 2,940 |
| Center Laboratories, Inc. | 10% Owner | 12/30/2021 | 1,982,541 |
| Center Laboratories, Inc. | 10% Owner | 05/20/2020 | 399,997 |
| Bioengine Capital Inc. | 10% Owner | 05/20/2020 | 399,997 |
| Bioengine Capital Inc. | 10% Owner | 12/30/2021 | 1,982,541 |
| Fraser Craig | President and CEO | 11/19/2021 | 1,488 |
| Fraser Craig | President and CEO | 11/18/2021 | 1,497 |
| Fraser Craig | President and CEO | 10/22/2021 | 5,700 |
| Huang James | Director | 10/19/2021 | 95,135 |
| Fraser Craig | President and CEO | 10/19/2021 | 5,730 |
| Hamill John P. | SVP & CFO | 04/16/2021 | 2,067 |
| Curtis Eric | SVP & COO | 04/07/2021 | 1,991 |
| Fraser Craig | President and CEO | 04/06/2021 | 1,285 |
| Fraser Craig | President and CEO | 04/01/2021 | 1,229 |
| Huang James | Director | 03/31/2021 | 354,000 |
| Fraser Craig | President and CEO | 03/31/2021 | 1,160 |
| Simonson Steven | SVP, Chief Medical Officer | 03/25/2021 | 4,875 |
| Hamill John P. | SVP & CFO | 03/25/2021 | 4,875 |
| Fraser Craig | President and CEO | 03/25/2021 | 4,875 |
| Fraser Craig | President and CEO | 10/28/2020 | 1,640 |
| Huang James | Director | 10/23/2020 | 6,666 |
| Huang James | Director | 06/04/2020 | 87,868 |
| Fraser Craig | President and CEO | 10/09/2020 | 1,456 |
| Hamill John P. | SVP & CFO | 10/07/2020 | 5,270 |
| Fraser Craig | President and CEO | 10/07/2020 | 1,293 |
| Curtis Eric | SVP & COO | 10/08/2020 | 2,635 |
| Huang James | Director | 06/04/2020 | 89,332 |
| Huang James | Director | 06/03/2020 | 1,484 |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | 05/22/2020 | 7,997 |
| Tattory John A | SVP & CFO | 05/22/2020 | 3,255 |
| Simonson Steven | SVP, Chief Medical Officer | 05/22/2020 | 3,748 |
| Fraser Craig | President and CEO | 05/22/2020 | 15,000 |
| Schreiber Brian D | Director | 05/22/2020 | 15,000 |
| PEACOCK BRUCE | Director | 05/22/2020 | 25,375 |
| Joseph Mahady M | Director | 05/22/2020 | 15,000 |
| Leone John R | Director | 05/22/2020 | 15,000 |
| Huang James | Director | 05/22/2020 | 2,000,000 |
| Geffken Daniel E. | Director | 05/22/2020 | 15,000 |
| Huang James | Director | 02/18/2020 | 1,535 |
| Fraser Craig | President and CEO | 02/11/2020 | 1,025 |
| Fraser Craig | President and CEO | 02/10/2020 | 1,025 |
| Huang James | Director | 02/07/2020 | 2,025 |
| Fraser Craig | President and CEO | 02/04/2020 | 2,120 |
| Fraser Craig | President and CEO | 02/03/2020 | 420 |
| Huang James | Director | 01/16/2020 | 244 |
| Huang James | Director | 01/17/2020 | 8,366 |
| Huang James | Director | 12/31/2019 | 62,525 |
| Huang James | Director | 12/30/2019 | 3,463 |
| Huang James | Director | 12/27/2019 | 15,261 |
| LPH II Investments Ltd | 10% Owner | 12/06/2019 | 5,000,000 |
| Lee's Pharmaceutical Holdings Ltd | 10% Owner | 12/06/2019 | 5,000,000 |
| Huang James | Director | 12/06/2019 | 5,000,000 |
| Tattory John A | SVP & CFO | 12/28/2018 | 40,035 |
| Simonson Steven | SVP, Chief Medical Officer | 12/28/2018 | 37,010 |
| Fraser Craig | President and CEO | 12/28/2018 | 77,765 |
| Lee's Pharmaceutical Holdings Ltd | 10% Owner | 12/21/2018 | 39,459,229 |
| LPH II Investments Ltd | 10% Owner | 12/21/2018 | 5,994,205 |
| Lee's Pharmaceutical Holdings Ltd | 10% Owner | 04/04/2018 | 2,600,002 |
| Fraser Craig | President and CEO | 10/28/2016 | 15,381 |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | 06/30/2016 | 2,250 |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | 03/31/2016 | 2,249 |
| Tattory John A | SVP & CFO | 06/30/2016 | 2,100 |
| Tattory John A | SVP & CFO | 03/31/2016 | 1,799 |
| Simonson Steven | SVP, Chief Development Officer | 06/30/2016 | 2,250 |
| Simonson Steven | SVP, Chief Development Officer | 03/31/2016 | 2,249 |
| Fraser Craig | President and CEO | 06/30/2016 | 2,081 |
| Tattory John A | Senior VP and CFO | 12/31/2015 | 2,473 |
| Tattory John A | Senior VP and CFO | 09/30/2015 | 2,549 |
| Simonson Steven | SVP, Chief Development Officer | 12/31/2015 | 7,864 |
| Simonson Steven | SVP, Chief Development Officer | 09/30/2015 | 3,377 |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | 12/31/2015 | 7,864 |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | 09/30/2015 | 3,377 |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | 06/30/2015 | 3,376 |
| Templeton Mary B Esq | SVP, Gen Counsel & Corp Sec | 03/31/2015 | 3,375 |
| Tattory John A | SVP & Chief Financial Officer | 03/31/2015 | 2,925 |
| Tattory John A | SVP & Chief Financial Officer | 06/30/2015 | 2,925 |
| Simonson Steven | SVP, Chief Development Officer | 06/30/2015 | 3,376 |
| Simonson Steven | SVP, Chief Development Officer | 03/31/2015 | 3,375 |
| COOPER JOHN G | President & CEO | 06/30/2015 | 3,376 |
| COOPER JOHN G | President & CEO | 03/31/2015 | 3,375 |
| Leone John R | Director | 02/19/2013 | 8,640 |
| Hoy Thomas | VP, Manufacturing | 03/31/2012 | 4,248 |
| Tattory John A | VP, Finance (Prin Acc Officer) | 03/31/2012 | 3,899 |
| Cole Kathy | Senior VP, Human Resources | 03/31/2012 | 4,250 |
| Templeton Mary B Esq | Senior VP, General Counsel | 03/31/2012 | 4,125 |
| Clayton Russell | Senior VP, R&D | 03/31/2012 | 4,250 |
| Miller Thomas F | Chief Operating Officer | 03/31/2012 | 4,250 |
| COOPER JOHN G | President & CFO | 03/31/2012 | 4,250 |
| Amick W Thomas | Chief Executive Officer | 03/31/2012 | 4,250 |
| Hoy Thomas | VP, Manufacturing | 09/30/2011 | 4,124 |
| Hoy Thomas | VP, Manufacturing | 06/30/2011 | 4,126 |
| Hoy Thomas | VP, Manufacturing | 03/31/2011 | 4,126 |
| Tattory John A | VP, Principal Acct Officer | 09/30/2011 | 3,601 |
| Tattory John A | VP, Principal Acct Officer | 06/30/2011 | 3,599 |
| Tattory John A | VP, Principal Acct Officer | 03/31/2011 | 3,600 |
| Templeton Mary B Esq | Senior VP, General Counsel | 09/30/2011 | 4,126 |
| Cole Kathy | Senior VP, Human Resources | 03/31/2011 | 4,126 |
| Cole Kathy | Senior VP, Human Resources | 09/30/2011 | 4,126 |
| Cole Kathy | Senior VP, Human Resources | 06/30/2011 | 4,126 |
| Miller Thomas F | Chief Operating Officer | 09/30/2011 | 4,126 |
| Miller Thomas F | Chief Operating Officer | 06/30/2011 | 4,126 |
| Miller Thomas F | Chief Operating Officer | 03/31/2011 | 4,126 |
| COOPER JOHN G | President & CFO | 09/30/2011 | 4,124 |
| Amick W Thomas | Chief Executive Officer | 09/30/2011 | 4,126 |
| Amick W Thomas | Chief Executive Officer | 06/30/2011 | 4,124 |
| Amick W Thomas | Chief Executive Officer | 03/31/2011 | 4,126 |
| COOPER JOHN G | President & CFO | 03/31/2011 | 4,126 |
| COOPER JOHN G | President & CFO | 06/30/2011 | 4,126 |
| LOPEZ DAVID L | Executive VP & General Counsel | 06/30/2011 | 4,126 |
| LOPEZ DAVID L | Executive VP & General Counsel | 03/31/2011 | 4,126 |
| LOPEZ DAVID L | Executive VP & Legal Counsel | 09/30/2010 | 1,961 |
| LOPEZ DAVID L | Executive VP & Legal Counsel | 12/17/2010 | 3,598 |
| Cole Kathy | Senior VP, Human Resources | 06/30/2010 | 2,063 |
| Cole Kathy | Senior VP, Human Resources | 03/31/2010 | 2,062 |
| COOPER JOHN G | Executive VP & CFO | 06/30/2010 | 2,063 |
| COOPER JOHN G | Executive VP & CFO | 03/31/2010 | 2,062 |
| COOPER JOHN G | Executive VP & CFO | 01/03/2010 | 2,087 |
| SEGAL ROBERT-MD | SVO, Chief Medical Officer | 06/30/2010 | 2,062 |
| SEGAL ROBERT-MD | SVO, Chief Medical Officer | 03/31/2010 | 2,063 |
| SEGAL ROBERT-MD | SVO, Chief Medical Officer | 01/03/2010 | 927 |
| Miller Thomas F | SVP, Commercial & Corp Dev | 06/30/2010 | 2,063 |
| Miller Thomas F | SVP, Commercial & Corp Dev | 03/31/2010 | 2,062 |
| Miller Thomas F | SVP, Commercial & Corp Dev | 01/03/2010 | 696 |
| LOPEZ DAVID L | Executive VP & Legal Counsel | 06/30/2010 | 2,164 |
| LOPEZ DAVID L | Executive VP & Legal Counsel | 03/31/2010 | 1,875 |
| LOPEZ DAVID L | Executive VP & Legal Counsel | 01/03/2010 | 2,087 |
Load More Insider Transactions
FUNDS WITH A POSITION IN WINDTREE THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 14,197 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR WINDTREE THERAPEUTICS INC
STOCK BUYBACKS FOR WINDTREE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
-3.82%
2Q
BUYBACK ANNOUNCEMENT(S) FOR WINDTREE THERAPEUTICS INC
LOADING...